Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesDividends payablesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Envoy Medical (COCH) Total Non-Current Liabilities (2022 - 2025)

Historic Total Non-Current Liabilities for Envoy Medical (COCH) over the last 4 years, with Q3 2025 value amounting to $14.0 million.

  • Envoy Medical's Total Non-Current Liabilities fell 4604.85% to $14.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $14.0 million, marking a year-over-year decrease of 4604.85%. This contributed to the annual value of $28.6 million for FY2024, which is 25215.41% up from last year.
  • Envoy Medical's Total Non-Current Liabilities amounted to $14.0 million in Q3 2025, which was down 4604.85% from $38.0 million recorded in Q2 2025.
  • In the past 5 years, Envoy Medical's Total Non-Current Liabilities registered a high of $38.0 million during Q2 2025, and its lowest value of $4.8 million during Q4 2022.
  • Moreover, its 4-year median value for Total Non-Current Liabilities was $17.2 million (2024), whereas its average is $19.7 million.
  • Its Total Non-Current Liabilities has fluctuated over the past 5 years, first surged by 25215.41% in 2024, then plummeted by 4604.85% in 2025.
  • Quarter analysis of 4 years shows Envoy Medical's Total Non-Current Liabilities stood at $4.8 million in 2022, then soared by 69.99% to $8.1 million in 2023, then skyrocketed by 252.15% to $28.6 million in 2024, then plummeted by 50.96% to $14.0 million in 2025.
  • Its Total Non-Current Liabilities stands at $14.0 million for Q3 2025, versus $38.0 million for Q2 2025 and $32.8 million for Q1 2025.